![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 15, 12440-12448, April 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the We investigated whether peroxisome
proliferator-activated receptor
Peroxisome Proliferator-activated Receptor
Ligands Suppress
the Transcriptional Activation of Cyclooxygenase-2
EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1 AND CREB-BINDING
PROTEIN/p300*
§¶,
,
, and
§
Department of Medicine (Division of
Gastroenterology and Hepatology), New York Presbyterian Hospital and
Weill Medical College of Cornell University, the § Strang
Cancer Prevention Center, and the
Department of Surgery (Head
and Neck Service), Memorial Sloan-Kettering Cancer Center,
New York, New York 10021
(PPAR
) ligands
(ciglitazone, troglitazone, and 15-deoxy-
12,14
prostaglandin J2) inhibited cyclooxygenase-2 (COX-2)
induction in human epithelial cells. Ligands of PPAR
inhibited
phorbol ester (phorbol 12-myristate 13-acetate, PMA)-mediated induction of COX-2 and prostaglandin E2 synthesis. Nuclear run-offs
revealed increased rates of COX-2 transcription after
treatment with PMA, an effect that was inhibited by PPAR
ligands.
PMA-mediated induction of COX-2 promoter activity was
inhibited by PPAR
ligands; this suppressive effect was prevented by
overexpressing a dominant negative form of PPAR
or a PPAR response
element decoy oligonucleotide. The stimulatory effects of PMA were
mediated by a cyclic AMP response element in the COX-2
promoter. Treatment with PMA increased activator protein-1 (AP-1)
activity and the binding of c-Jun, c-Fos, and ATF-2 to the cyclic AMP
response element, effects that were blocked by PPAR
ligands. These
findings raised questions about the mechanism underlying the anti-AP-1
effect of PPAR
ligands. The induction of c-Jun by PMA was blocked by
PPAR
ligands. Overexpression of either c-Jun or CREB-binding
protein/p300 partially relieved the suppressive effect of PPAR
ligands. When CREB-binding protein and c-Jun were overexpressed
together, the ability of PPAR
ligands to suppress PMA-mediated
induction of COX-2 promoter activity was essentially
abrogated. Bisphenol A diglycidyl ether, a compound that binds to
PPAR
but lacks the ability to activate transcription, also inhibited
PMA-mediated induction of AP-1 activity and COX-2. Taken together,
these findings are likely to be important for understanding the
anti-inflammatory and anti-cancer properties of PPAR
ligands.
*
This work was supported in part by National Institutes of
Health Grants P01 CA29502, 1 R01 CA89578, and T32 CA09685, the Cancer Research Foundation of America, and the James E. Olson Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. Jahoor, R. Patel, A. Bryan, C. Do, J. Krier, C. Watters, W. Wahli, G. Li, S. C. Williams, and K. P. Rumbaugh Peroxisome Proliferator-Activated Receptors Mediate Host Cell Proinflammatory Responses to Pseudomonas aeruginosa Autoinducer J. Bacteriol., July 1, 2008; 190(13): 4408 - 4415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah and A. J. Dannenberg Cyclooxygenase-2 Transcription Is Regulated by Human Papillomavirus 16 E6 and E7 Oncoproteins: Evidence of a Corepressor/Coactivator Exchange Cancer Res., April 15, 2007; 67(8): 3976 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Chambers, S. M. Weber, and J. A. Corbett PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1052 - E1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Froment, F Gizard, D Defever, B Staels, J Dupont, and P Monget Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J. Endocrinol., May 1, 2006; 189(2): 199 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-N. Lin, W.-M. Cheung, J.-S. Wu, J.-J. Chen, H. Lin, J.-J. Chen, J.-Y. Liou, S.-K. Shyue, and K. K. Wu 15d-Prostaglandin J2 Protects Brain From Ischemia-Reperfusion Injury Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schupp, L. D. Lee, N. Frost, S. Umbreen, B. Schmidt, T. Unger, and U. Kintscher Regulation of Peroxisome Proliferator-Activated Receptor {gamma} Activity by Losartan Metabolites Hypertension, March 1, 2006; 47(3): 586 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Wang, C.-Y. Ko, L.-C. Chen, W.-L. Wang, and W.-C. Chang Functional role of NF-IL6{beta} and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene Nucleic Acids Res., January 5, 2006; 34(1): 217 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Chang, M.-S. Wu, J.-T. Lin, and C.-C. Chen Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation J. Immunol., December 15, 2005; 175(12): 8242 - 8252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, J. D. Ritzenthaler, H. N. Rivera, and J. Roman Peroxisome proliferator-activated receptor-{gamma} ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1 Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L419 - L428. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Ackerman IV, X. L. Zhang, B. H. Rovin, and D. A. Kniss Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NF{kappa}B Signal Disruption in Human WISH and Amnion Cells Biol Reprod, September 1, 2005; 73(3): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luna-Medina, M. Cortes-Canteli, M. Alonso, A. Santos, A. Martinez, and A. Perez-Castillo Regulation of Inflammatory Response in Neural Cells in Vitro by Thiadiazolidinones Derivatives through Peroxisome Proliferator-activated Receptor {gamma} Activation J. Biol. Chem., June 3, 2005; 280(22): 21453 - 21462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M Lindstrom and P. R Bennett 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Interleukin-1{beta}-Induced Nuclear Factor-{kappa}B in Human Amnion and Myometrial Cells: Mechanisms and Implications J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3534 - 3543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway Mol. Pharmacol., May 1, 2005; 67(5): 1620 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, M. Zhao, R. Rao, H. Inoue, and C.-M. Hao C/EBP{beta} and Its Binding Element Are Required for NF{kappa}B-induced COX2 Expression Following Hypertonic Stress J. Biol. Chem., April 22, 2005; 280(16): 16354 - 16359. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kong, H.-T. Kim, K. Wu, D. DeNardo, S. G. Hilsenbeck, X.-C. Xu, W. W. Lamph, R. Bissonnette, A. J. Dannenberg, and P. H. Brown The Retinoid X Receptor-Selective Retinoid, LGD1069, Down-regulates Cyclooxygenase-2 Expression in Human Breast Cells through Transcription Factor Crosstalk: Implications for Molecular-Based Chemoprevention Cancer Res., April 15, 2005; 65(8): 3462 - 3469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ray, F. Akbiyik, S. H. Bernstein, and R. P. Phipps CD40 Engagement Prevents Peroxisome Proliferator-Activated Receptor {gamma} Agonist-Induced Apoptosis of B Lymphocytes and B Lymphoma Cells by an NF-{kappa}B-Dependent Mechanism J. Immunol., April 1, 2005; 174(7): 4060 - 4069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Wu, C.-A. Wang, C.-C. Lin, L.-C. Chen, W.-C. Chang, and S.-J. Tsai Distinct Regulation of Cyclooxygenase-2 by Interleukin-1{beta} in Normal and Endometriotic Stromal Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 286 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Weber, K. T. Chambers, K. G. Bensch, A. L. Scarim, and J. A. Corbett PPAR{gamma} ligands induce ER stress in pancreatic {beta}-cells: ER stress activation results in attenuation of cytokine signaling Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1171 - E1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sabichi, V. Subbarayan, N. Llansa, S. M. Lippman, and D. G. Menter Peroxisome Proliferator-Activated Receptor-{gamma} Suppresses Cyclooxygenase-2 Expression in Human Prostate Cells Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1704 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grau, M. A. Iniguez, and M. Fresno Inhibition of Activator Protein 1 Activation, Vascular Endothelial Growth Factor, and Cyclooxygenase-2 Expression by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Colon Carcinoma Cells: Evidence for a Redox-Sensitive Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism Cancer Res., August 1, 2004; 64(15): 5162 - 5171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mitsuhashi, J. Liu, S. Cao, X. Shi, and X. Ma Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas J. Leukoc. Biol., August 1, 2004; 76(2): 322 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cunard, Y. Eto, J. T. Muljadi, C. K. Glass, C. J. Kelly, and M. Ricote Repression of IFN-{gamma} Expression by Peroxisome Proliferator-Activated Receptor {gamma} J. Immunol., June 15, 2004; 172(12): 7530 - 7536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cheron, J. Peltier, J. Perez, A. Bellocq, B. Fouqueray, and L. Baud 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Glucocorticoid Binding and Signaling in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Process J. Immunol., June 15, 2004; 172(12): 7677 - 7683. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. WARNER and J. A. MITCHELL Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic FASEB J, May 1, 2004; 18(7): 790 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Varley, J. Stahlschmidt, B. Smith, M. Stower, and J. Southgate Activation of Peroxisome Proliferator-Activated Receptor-{gamma} Reverses Squamous Metaplasia and Induces Transitional Differentiation in Normal Human Urothelial Cells Am. J. Pathol., May 1, 2004; 164(5): 1789 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, G. L. Borchert, and J. M. Phang Polyoma Enhancer Activator 3, an Ets Transcription Factor, Mediates the Induction of Cyclooxygenase-2 by Nitric Oxide in Colorectal Cancer Cells J. Biol. Chem., April 30, 2004; 279(18): 18694 - 18700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Varley, J. Stahlschmidt, W.-C. Lee, J. Holder, C. Diggle, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Role of PPAR {gamma} and EGFR signalling in the urothelial terminal differentiation programme J. Cell Sci., April 15, 2004; 117(10): 2029 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
W K Leung, A H C Bai, V Y W Chan, J Yu, M W Y Chan, K-F To, J-R Wu, K-K Chan, Y-G Fu, F K L Chan, et al. Effect of peroxisome proliferator activated receptor {gamma} ligands on growth and gene expression profiles of gastric cancer cells Gut, March 1, 2004; 53(3): 331 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Badawi, M. B. Eldeen, Y. Liu, E. A. Ross, and M. Z. Badr Inhibition of Rat Mammary Gland Carcinogenesis by Simultaneous Targeting of Cyclooxygenase-2 and Peroxisome Proliferator-activated Receptor {gamma} Cancer Res., February 1, 2004; 64(3): 1181 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Perez-Sala, E. Cernuda-Morollon, and F. J. Canada Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-{Delta}12,14-prostaglandin J2 J. Biol. Chem., December 19, 2003; 278(51): 51251 - 51260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nie, L. Pang, H. Inoue, and A. J Knox Transcriptional Regulation of Cyclooxygenase 2 by Bradykinin and Interleukin-1{beta} in Human Airway Smooth Muscle Cells: Involvement of Different Promoter Elements, Transcription Factors, and Histone H4 Acetylation Mol. Cell. Biol., December 15, 2003; 23(24): 9233 - 9244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Chung, B. Y. Kang, and T. S. Kim Inhibition of Interleukin-4 Production in CD4+ T Cells by Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR-{gamma}) Ligands: Involvement of Physical Association between PPAR-{gamma} and the Nuclear Factor of Activated T Cells Transcription Factor Mol. Pharmacol., November 1, 2003; 64(5): 1169 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, H. Inoue, L. C. Flowers, and N. Sidell Control of COX-2 Gene Expression through Peroxisome Proliferator-Activated Receptor {gamma} in Human Cervical Cancer Cells Clin. Cancer Res., October 1, 2003; 9(12): 4627 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mendez and M. C. LaPointe PPAR{gamma} Inhibition of Cyclooxygenase-2, PGE2 Synthase, and Inducible Nitric Oxide Synthase in Cardiac Myocytes Hypertension, October 1, 2003; 42(4): 844 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, D. Yan, C. Yan, and H. Du Peroxisome Proliferator-activated Receptor {gamma} and Ligands Inhibit Surfactant Protein B Gene Expression in the Lung J. Biol. Chem., September 19, 2003; 278(38): 36841 - 36847. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Chun, Y.-S. Keum, S. S. Han, Y.-S. Song, S.-H. Kim, and Y.-J. Surh Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-{kappa}B activation Carcinogenesis, September 1, 2003; 24(9): 1515 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. LEVINE Does the release of arachidonic acid from cells play a role in cancer chemoprevention? FASEB J, May 1, 2003; 17(8): 800 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Weber, A. L. Scarim, and J. A. Corbett Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2 Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E883 - E891. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu, M. Marko, K. Claycombe, K. E. Paulson, and S. N. Meydani Ceramide-induced and Age-associated Increase in Macrophage COX-2 Expression Is Mediated through Up-regulation of NF-kappa B Activity J. Biol. Chem., March 21, 2003; 278(13): 10983 - 10992. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barat and M. J. Tremblay Treatment of Human T Cells with Bisperoxovanadium Phosphotyrosyl Phosphatase Inhibitors Leads to Activation of Cyclooxygenase-2 Gene J. Biol. Chem., February 21, 2003; 278(9): 6992 - 7000. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-G. Deng, Y. Zhu, and K. K. Wu Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-alpha -induced Cyclooxygenase-2 Promoter Activation J. Biol. Chem., February 7, 2003; 278(7): 4770 - 4777. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pang, M. Nie, L. Corbett, and A. J. Knox Cyclooxygenase-2 Expression by Nonsteroidal Anti-inflammatory Drugs in Human Airway Smooth Muscle Cells: Role of Peroxisome Proliferator-Activated Receptors J. Immunol., January 15, 2003; 170(2): 1043 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Cheng and R. C. Harris Cyclooxygenase-2 Expression in Cultured Cortical Thick Ascending Limb of Henle Increases in Response to Decreased Extracellular Ionic Content by Both Transcriptional and Post-transcriptional Mechanisms. ROLE OF p38-MEDIATED PATHWAYS J. Biol. Chem., November 15, 2002; 277(47): 45638 - 45643. [Abstract] [Full Text] [PDF] |
||||
![]() |
Shuling Zhang, K. Thomas, J. C.G. Blanco, C. A. Salkowski, and S. N. Vogel The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro Innate Immunity, October 1, 2002; 8(5): 381 - 390. [Abstract] [PDF] |
||||
![]() |
K. Schroer, Y. Zhu, M. A. Saunders, W.-G. Deng, X.-M. Xu, J. Meyer-Kirchrath, and K. K. Wu Obligatory Role of Cyclic Adenosine Monophosphate Response Element in Cyclooxygenase-2 Promoter Induction and Feedback Regulation by Inflammatory Mediators Circulation, June 11, 2002; 105(23): 2760 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Hartman, X. Hu, K. X. Tyler, C. K. Dalal, and M. A. Lazar Mechanisms Regulating Adipocyte Expression of Resistin J. Biol. Chem., May 24, 2002; 277(22): 19754 - 19761. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, L. Norton, W. Gerald, and A. J. Dannenberg Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer. EVIDENCE FOR INVOLVEMENT OF AP-1 AND PEA3 J. Biol. Chem., May 17, 2002; 277(21): 18649 - 18657. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, P. A. Cole, and A. J. Dannenberg Retinoids and Carnosol Suppress Cyclooxygenase-2 Transcription by CREB-binding Protein/p300-dependent and -independent Mechanisms Cancer Res., May 1, 2002; 62(9): 2522 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Pontsler, A. St. Hilaire, G. K. Marathe, G. A. Zimmerman, and T. M. McIntyre Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome Proliferator Activated Receptor gamma and Oxidized Alkyl Phospholipids from Oxidized Low Density Lipoprotein J. Biol. Chem., April 5, 2002; 277(15): 13029 - 13036. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Clay, G.-i. Atsumi, K. P. High, and F. H. Chilton Early de Novo Gene Expression Is Required for 15-Deoxy-Delta 12,14-prostaglandin J2-induced Apoptosis in Breast Cancer Cells J. Biol. Chem., December 7, 2001; 276(50): 47131 - 47135. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Gupta, D. B. Polk, U. Krishna, D. A. Israel, F. Yan, R. N. DuBois, and R. M. Peek Jr. Activation of Peroxisome Proliferator-activated Receptor gamma Suppresses Nuclear Factor kappa B-mediated Apoptosis Induced by Helicobacter pylori in Gastric Epithelial Cells J. Biol. Chem., August 10, 2001; 276(33): 31059 - 31066. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |